Arrhythmia Research Technology Stock Price, News & Analysis
Company Description
Arrhythmia Research Technology (NYSE: HRT) is a publicly traded human resources consulting services company in the Services-business Services, Nec sector. The company has a market capitalization of $967.2M, ranking #2,938 among all listed U.S. companies by market cap.
HRT stock has declined 100.0% over the past year. Shares last traded at $14.36.
This page provides a comprehensive overview of HRT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Arrhythmia Research Technology (HRT) stock last traded at $14.36. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $967.2M, HRT is classified as a small-cap stock with approximately 67.3M shares outstanding.
HRT Rankings
Latest News
Arrhythmia Research Technology has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, earnings, conferences, management. View all HRT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
HRT Company Profile & Sector Positioning
Arrhythmia Research Technology (HRT) operates in the Human Resources Consulting Services industry within the broader Services-business Services, Nec sector and is listed on the NYSE.